Bulletin
Investor Alert

New York Markets Open in:

Market Snapshot Analyst Ratings

Annovis Bio Inc.

NYS: ANVS

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Annovis Bio Inc.

After Hours

 --Quotes are delayed by 20 min

Jan 25, 2022, 5:47 p.m.

ANVS
/zigman2/quotes/216213707/composite

$

14.30

Change

+0.28 +2.00%

Volume

Volume 404

Quotes are delayed by 20 min

/zigman2/quotes/216213707/composite

Previous close

$ 13.82

$ 14.02

Change

+0.20 +1.45%

Day low

Day high

$13.02

$15.00

Open

52 week low

52 week high

$9.71

$132.00

Open
Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Annovis Bio Inc.

View Ratios

Operating Activities

Fiscal year is January-December. All values USD millions. 2017201820192020 5-year trend
Net Income before Extraordinaries -(682,349)(713,871)(990,980)(5.46M)
Depreciation, Depletion & Amortization -----
Depreciation and Depletion -----
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit -----
Deferred Taxes -----
Investment Tax Credit -----
Other Funds -48,49582,72892,9121.89M
Funds from Operations -(633,854)(631,143)(898,068)(3.57M)
Extraordinaries -----
Changes in Working Capital -96,37372,534421,526(400,714)
Receivables ---(735,075)735,075
Accounts Payable -36,914(2,682)969,091(695,660)
Other Assets/Liabilities -(2,368)(5,189)5,101(34,097)
Net Operating Cash Flow -(537,481)(558,609)(476,542)(3.97M)

Investing Activities

2017201820192020 5-year trend
Capital Expenditures -----
Capital Expenditures (Fixed Assets) -----
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses -----
Purchase/Sale of Investments -----
Purchase of Investments -----
Sale/Maturity of Investments -----
Other Uses -----
Other Sources -----
Net Investing Cash Flow -----

Financing Activities

2017201820192020 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock -332,495246,449(78,611)9,217
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock -332,495246,449(78,611)9,217
Proceeds from Stock Options -332,495246,449(78,611)9,217
Other Proceeds from Sale of Stock -----
Issuance/Reduction of Debt, Net ---521,69912.03M
Change in Current Debt -----
Change in Long-Term Debt ---521,69912.03M
Issuance of Long-Term Debt ---521,69912.03M
Reduction in Long-Term Debt -----
Other Funds -----
Other Uses -----
Other Sources -----
Net Financing Cash Flow -332,495246,449443,08812.04M
Exchange Rate Effect -----
Miscellaneous Funds -----
Net Change in Cash -(204,986)(312,160)(33,454)8.07M
Free Cash Flow -(537,480)(558,610)(476,540)(3.97M)
Copyright 2022 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Trending Tickers
  • /zigman2/quotes/201786389/composite USA+0.11%
  • /zigman2/quotes/205971581/composite VIXM+1.50%
  • /zigman2/quotes/204412041/composite KMX+0.98%
  • /zigman2/quotes/205782082/composite IT-0.70%
  • /zigman2/quotes/200387963/composite LINK+1.77%
X
Powered by StockTwits
Link to MarketWatch's Slice.